Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fatih M Uckun

Showing results (1-10 of 186) with videos related to

Pageof 19
Sort By:
Cancer Drug Resistance (Alhambra, Calif.)|July 8, 2022
Cancer drug resistance in multiple myelomaFatih M Uckun
Cell Cycle (Georgetown, Tex.)|December 13, 2007
Chemosensitizing anti-cancer activity of LFM-A13, a leflunomide metabolite analog targeting polo-like kinasesFatih M Uckun
Frontiers in Oncology|December 3, 2021
Dual Targeting of Multiple Myeloma Stem Cells and Myeloid-Derived Suppressor Cells for Treatment of Chemotherapy-Resistant Multiple MyelomaFatih M Uckun
International Reviews of Immunology|February 27, 2008
Clinical potential of targeting Bruton's tyrosine kinaseFatih M Uckun
Arzneimittel-Forschung|March 31, 2006
Stampidine as a novel nucleoside reverse transcriptase inhibit with potent anti-HIV activityFatih M Uckun
Frontiers in Pharmacology|June 24, 2020
Reducing the Fatality Rate of COVID-19 by Applying Clinical Insights From Immuno-Oncology and Lung TransplantationFatih M Uckun
Cancers|April 30, 2021
Overcoming the Immunosuppressive Tumor Microenvironment in Multiple MyelomaFatih M Uckun
Arzneimittel-Forschung|March 31, 2006
Unmet challenges in HIV therapy and potential of stampidineFatih M Uckun
Expert Review of Anticancer Therapy|September 15, 2010
Spleen tyrosine kinase as a molecular target for treatment of leukemias and lymphomasFatih M Uckun, Sanjive Qazi
Current Pharmaceutical Design|April 14, 2004
Tyrosine kinases as new molecular targets in treatment of inflammatory disorders and leukemiaFatih M Uckun, Chen Mao
Pageof 19

Showing results (1-10 of 186) with videos related to

Sort By:
Pageof 19
Cancer Drug Resistance (Alhambra, Calif.)|July 8, 2022
Cancer drug resistance in multiple myelomaFatih M Uckun
Cell Cycle (Georgetown, Tex.)|December 13, 2007
Chemosensitizing anti-cancer activity of LFM-A13, a leflunomide metabolite analog targeting polo-like kinasesFatih M Uckun
Frontiers in Oncology|December 3, 2021
Dual Targeting of Multiple Myeloma Stem Cells and Myeloid-Derived Suppressor Cells for Treatment of Chemotherapy-Resistant Multiple MyelomaFatih M Uckun
International Reviews of Immunology|February 27, 2008
Clinical potential of targeting Bruton's tyrosine kinaseFatih M Uckun
Arzneimittel-Forschung|March 31, 2006
Stampidine as a novel nucleoside reverse transcriptase inhibit with potent anti-HIV activityFatih M Uckun
Frontiers in Pharmacology|June 24, 2020
Reducing the Fatality Rate of COVID-19 by Applying Clinical Insights From Immuno-Oncology and Lung TransplantationFatih M Uckun
Cancers|April 30, 2021
Overcoming the Immunosuppressive Tumor Microenvironment in Multiple MyelomaFatih M Uckun
Arzneimittel-Forschung|March 31, 2006
Unmet challenges in HIV therapy and potential of stampidineFatih M Uckun
Expert Review of Anticancer Therapy|September 15, 2010
Spleen tyrosine kinase as a molecular target for treatment of leukemias and lymphomasFatih M Uckun, Sanjive Qazi
Current Pharmaceutical Design|April 14, 2004
Tyrosine kinases as new molecular targets in treatment of inflammatory disorders and leukemiaFatih M Uckun, Chen Mao
Pageof 19